1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow PF-04523655: new trials by email Literature Review of PF-04523655 trials Research Report on PF-04523655
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) PF-04523655 - Age-Related Macular Degeneration | Phase 1 | Completed | Quark Pharmaceuticals | 54 | 2007-02-01 | 2012-10-10 |
Choroidal Neovascularization (1) · Macular Degeneration (1)
Israel (1) · United States (1)